Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats

Claire A. Schreiber, Sara J. Holditch, Alex Generous, Yasuhiro H Ikeda

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Elabela (ELA) is a recently identified apelin receptor agonist essential for cardiac development, but its biology and therapeutic potential are unclear. In humans, ELA transcripts are detected in embryonic stem cells, induced pluripotent stem cells, kidney, heart and blood vessels. ELA through the apelin (APJ) receptor promotes angiogenesis in vitro, relaxes murine aortic blood vessels and attenuates high blood pressure in vivo. The APJ receptor when bound to its original ligand, apelin, exerts peripheral vasodilatory and positive inotropic effects, conferring cardioprotection in vivo. Methods: This study initially assessed endogenous ELA expression in normal and diseased rats and then characterized the effects of long-term ELA gene delivery by adeno-associated virus serotype 9 (AAV9) vectors on cardiorenal function in Dahl salt-sensitive rats (DS) on a high-salt diet over 3 months. Results: Endogenous ELA was predominantly expressed in the kidneys, especially in the renal collecting duct cells and was not affected by disease. Rat ELA was overexpressed in the heart via AAV9 vector by a single intravenous injection. ELA-treated animals showed delayed onset of blood pressure elevation. Prior to high-salt diet, a reduction in the fractional sodium and chloride excretion was observed in rats given the AAV9-ELA vector. After three months on a high-salt diet, ELA preserved glomerular architecture, decreased renal fibrosis and suppressed expression of fibrosis-associated genes in the kidneys. Conclusion: ELA is constitutively expressed in renal collecting ducts in rats. Sustained AAV-ELA expression may offer a potential long-term therapy for hypertension and renal remodeling.

Original languageEnglish (US)
Pages (from-to)349-360
Number of pages12
JournalCurrent Gene Therapy
Volume16
Issue number5
DOIs
StatePublished - Oct 1 2016

Fingerprint

Genetic Therapy
Salts
Diet
Kidney
Dependovirus
Blood Vessels
Fibrosis
Inbred Dahl Rats
Induced Pluripotent Stem Cells
Renal Hypertension
Embryonic Stem Cells
Sodium Chloride
Intravenous Injections
Genes
Blood Pressure
Ligands
Hypertension
Therapeutics
Serogroup

Keywords

  • AAV
  • APJ
  • DS
  • Elabela
  • Hypertension
  • Renal fibrosis

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Drug Discovery
  • Genetics(clinical)

Cite this

Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats. / Schreiber, Claire A.; Holditch, Sara J.; Generous, Alex; Ikeda, Yasuhiro H.

In: Current Gene Therapy, Vol. 16, No. 5, 01.10.2016, p. 349-360.

Research output: Contribution to journalArticle

Schreiber, Claire A. ; Holditch, Sara J. ; Generous, Alex ; Ikeda, Yasuhiro H. / Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats. In: Current Gene Therapy. 2016 ; Vol. 16, No. 5. pp. 349-360.
@article{f4aa16f011b0481c8b9732f7092384ed,
title = "Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats",
abstract = "Background: Elabela (ELA) is a recently identified apelin receptor agonist essential for cardiac development, but its biology and therapeutic potential are unclear. In humans, ELA transcripts are detected in embryonic stem cells, induced pluripotent stem cells, kidney, heart and blood vessels. ELA through the apelin (APJ) receptor promotes angiogenesis in vitro, relaxes murine aortic blood vessels and attenuates high blood pressure in vivo. The APJ receptor when bound to its original ligand, apelin, exerts peripheral vasodilatory and positive inotropic effects, conferring cardioprotection in vivo. Methods: This study initially assessed endogenous ELA expression in normal and diseased rats and then characterized the effects of long-term ELA gene delivery by adeno-associated virus serotype 9 (AAV9) vectors on cardiorenal function in Dahl salt-sensitive rats (DS) on a high-salt diet over 3 months. Results: Endogenous ELA was predominantly expressed in the kidneys, especially in the renal collecting duct cells and was not affected by disease. Rat ELA was overexpressed in the heart via AAV9 vector by a single intravenous injection. ELA-treated animals showed delayed onset of blood pressure elevation. Prior to high-salt diet, a reduction in the fractional sodium and chloride excretion was observed in rats given the AAV9-ELA vector. After three months on a high-salt diet, ELA preserved glomerular architecture, decreased renal fibrosis and suppressed expression of fibrosis-associated genes in the kidneys. Conclusion: ELA is constitutively expressed in renal collecting ducts in rats. Sustained AAV-ELA expression may offer a potential long-term therapy for hypertension and renal remodeling.",
keywords = "AAV, APJ, DS, Elabela, Hypertension, Renal fibrosis",
author = "Schreiber, {Claire A.} and Holditch, {Sara J.} and Alex Generous and Ikeda, {Yasuhiro H}",
year = "2016",
month = "10",
day = "1",
doi = "10.2174/1566523217666161121111906",
language = "English (US)",
volume = "16",
pages = "349--360",
journal = "Current Gene Therapy",
issn = "1566-5232",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Sustained ELABELA gene therapy in high-salt diet-induced hypertensive rats

AU - Schreiber, Claire A.

AU - Holditch, Sara J.

AU - Generous, Alex

AU - Ikeda, Yasuhiro H

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background: Elabela (ELA) is a recently identified apelin receptor agonist essential for cardiac development, but its biology and therapeutic potential are unclear. In humans, ELA transcripts are detected in embryonic stem cells, induced pluripotent stem cells, kidney, heart and blood vessels. ELA through the apelin (APJ) receptor promotes angiogenesis in vitro, relaxes murine aortic blood vessels and attenuates high blood pressure in vivo. The APJ receptor when bound to its original ligand, apelin, exerts peripheral vasodilatory and positive inotropic effects, conferring cardioprotection in vivo. Methods: This study initially assessed endogenous ELA expression in normal and diseased rats and then characterized the effects of long-term ELA gene delivery by adeno-associated virus serotype 9 (AAV9) vectors on cardiorenal function in Dahl salt-sensitive rats (DS) on a high-salt diet over 3 months. Results: Endogenous ELA was predominantly expressed in the kidneys, especially in the renal collecting duct cells and was not affected by disease. Rat ELA was overexpressed in the heart via AAV9 vector by a single intravenous injection. ELA-treated animals showed delayed onset of blood pressure elevation. Prior to high-salt diet, a reduction in the fractional sodium and chloride excretion was observed in rats given the AAV9-ELA vector. After three months on a high-salt diet, ELA preserved glomerular architecture, decreased renal fibrosis and suppressed expression of fibrosis-associated genes in the kidneys. Conclusion: ELA is constitutively expressed in renal collecting ducts in rats. Sustained AAV-ELA expression may offer a potential long-term therapy for hypertension and renal remodeling.

AB - Background: Elabela (ELA) is a recently identified apelin receptor agonist essential for cardiac development, but its biology and therapeutic potential are unclear. In humans, ELA transcripts are detected in embryonic stem cells, induced pluripotent stem cells, kidney, heart and blood vessels. ELA through the apelin (APJ) receptor promotes angiogenesis in vitro, relaxes murine aortic blood vessels and attenuates high blood pressure in vivo. The APJ receptor when bound to its original ligand, apelin, exerts peripheral vasodilatory and positive inotropic effects, conferring cardioprotection in vivo. Methods: This study initially assessed endogenous ELA expression in normal and diseased rats and then characterized the effects of long-term ELA gene delivery by adeno-associated virus serotype 9 (AAV9) vectors on cardiorenal function in Dahl salt-sensitive rats (DS) on a high-salt diet over 3 months. Results: Endogenous ELA was predominantly expressed in the kidneys, especially in the renal collecting duct cells and was not affected by disease. Rat ELA was overexpressed in the heart via AAV9 vector by a single intravenous injection. ELA-treated animals showed delayed onset of blood pressure elevation. Prior to high-salt diet, a reduction in the fractional sodium and chloride excretion was observed in rats given the AAV9-ELA vector. After three months on a high-salt diet, ELA preserved glomerular architecture, decreased renal fibrosis and suppressed expression of fibrosis-associated genes in the kidneys. Conclusion: ELA is constitutively expressed in renal collecting ducts in rats. Sustained AAV-ELA expression may offer a potential long-term therapy for hypertension and renal remodeling.

KW - AAV

KW - APJ

KW - DS

KW - Elabela

KW - Hypertension

KW - Renal fibrosis

UR - http://www.scopus.com/inward/record.url?scp=85013864393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013864393&partnerID=8YFLogxK

U2 - 10.2174/1566523217666161121111906

DO - 10.2174/1566523217666161121111906

M3 - Article

C2 - 27903222

AN - SCOPUS:85013864393

VL - 16

SP - 349

EP - 360

JO - Current Gene Therapy

JF - Current Gene Therapy

SN - 1566-5232

IS - 5

ER -